The heavy selling pressure might have exhausted for TrueCar (TRUE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
TrueCar, Inc. (TRUE) Q4 2024 Earnings Call Transcript
While the top- and bottom-line numbers for TrueCar (TRUE) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
TrueCar (TRUE) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to break-even earnings per share a year ago.
TrueCar (TRUE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
In partnership with DAV (Disabled American Veterans), TrueCar recognizes veteran for continued service to community SANTA MONICA, Calif. , Dec. 26, 2024 /PRNewswire/ -- TrueCar, Inc. (NASDAQ: TRUE), the most trusted automotive digital marketplace, awarded a new vehicle to Army veteran Yusuf Henriques of Alexandria, Virginia.
TrueCar, Inc. (NASDAQ:TRUE ) Q3 2024 Earnings Conference Call November 7, 2024 9:00 AM ET Company Participants Jantoon Reigersman - President, CEO & Director Oliver Foley - CFO Conference Call Participants Marvin Fong - BTIG Ryan Meyers - Lake Street Rajat Gupta - JPMorgan Chris Pierce - Needham Ryan Pfingst - B. Riley Securities Wyatt Swanson - D.A.
The headline numbers for TrueCar (TRUE) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Treatment.com AI CEO, Dr. Essam Hamza, is to present live at 11:00 AM ET on Wednesday, October 9, 2024 Vancouver, British Columbia--(Newsfile Corp. - October 1, 2024) - Treatment.com AI Inc. (CSE: TRUE) (OTCQB: TREIF) (FSE: 939) ("Treatment"), a healthcare tech company focused on transforming patient care with AI-driven Clinical insights, is pleased to announce its participation at the upcoming Cantech Letter Investment Conference on Wednesday, October 9, 2024 in Toronto Ontario. Dr. Essam Hamza, CEO of Treatment.com AI , will be attending the conference, delivering an investor presentation and participating in scheduled 1-on-1 meetings with investors at the conference.
SANTA MONICA, Calif. , Aug. 16, 2024 /PRNewswire/ -- TrueCar, Inc., (NASDAQ:TRUE), the easiest, most efficient and transparent online destination for buying and selling new and used vehicles, today announced that its Chief People Officer & Operations, Jill Angel, has been appointed as Chief Operating Officer, effective immediately.